Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
35.3M
-
Shares change
-
+708K
-
Total reported value, excl. options
-
$520M
-
Value change
-
-$7.93M
-
Put/Call ratio
-
0
-
Number of buys
-
62
-
Number of sells
-
-44
-
Price
-
$14.72
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q2 2022
123 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q2 2022.
Pulmonx Corp - COMMON STOCK (LUNG) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.3M shares
of 40.4M outstanding shares and own 87.5% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.4M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.47M shares), VANGUARD GROUP INC (3.13M shares), BlackRock Inc. (2.43M shares), Champlain Investment Partners, LLC (2.13M shares), MORGAN STANLEY (2.13M shares), PURA VIDA INVESTMENTS, LLC (1.33M shares), TimesSquare Capital Management, LLC (1.21M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (923K shares), and Jefferies Group LLC (895K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.